Diagnostic imaging in the evaluation of renal lymphoma. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Diagnostic imaging in the evaluation of renal lymphoma.

Leuk Lymphoma. 1994 Dec;16(1-2):37-50. Unique Identifier : AIDSLINE MED/95210983
Eisenberg PJ; Papanicolaou N; Lee MJ; Yoder IC; Department of Radiology, Massachusetts General Hospital and; Harvard Medical School, Boston, MA 02114.


Abstract: Renal lymphoma usually is a manifestation of disseminated disease and often is asymptomatic. Occasionally, the kidney(s) may be the major or only demonstrable site of disease, which may then present with a variety of urologic symptoms. The imaging studies should be tailored according to the presenting symptoms and prior history. Currently CT with intravenous contrast material enhancement is the study of choice for both the evaluation of renal involvement as well as staging of the disease. When necessary, CT or sonography may be used to guide percutaneous needle biopsy of suspicious masses. The role of the various imaging techniques, including MR and positron emission tomography, in the evaluation of renal lymphoma is discussed.
Keywords: Angiography Human Kidney Neoplasms/*DIAGNOSIS/PATHOLOGY Kidney Transplantation/ADVERSE EFFECTS Lymphoma/*DIAGNOSIS/PATHOLOGY Lymphoma, AIDS-Related/DIAGNOSIS/PATHOLOGY Magnetic Resonance Imaging Radionuclide Imaging Tomography, X-Ray Computed Ultrasonography Urography JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDangiographyhumankidneyneoplasms/KWDdiagnosis/pathologykidneytransplantation/adverseeffectslymphoma/KWDdiagnosis/pathologylymphoma,aids-related/diagnosis/pathologymagneticresonanceimagingradionuclideimagingtomography,x-raycomputedultrasonographyurographyjournalarticlereviewreview,tutorial
950730
M9570925

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .